An observational study in Pulmonary Disease, Chronic Obstructive, Disease Exacerbation and Pulmonary Embolism, sponsored by Hillel Yaffe Medical Center. Status unknown at 1 site in Israel. Open to participants aged 18 Years and older. Per ClinicalTrials.gov, last updated 2010-03-02.
Sponsored by Hillel Yaffe Medical Center · Observational
To determine the possible association of prothrombin fragments 1+2 elevation with incidents of pulmonary embolism in patients with COPD exacerbation.
739 studies on the registry are indexed under Pulmonary Embolism; 159 are open to participants now.
Browse Pulmonary Embolism studies →Hillel Yaffe Medical Center is the lead sponsor of 301 studies on the registry; 10 are open to participants now.
Counted across the registry records on this site, refreshed daily.
Patients admitted to hospital due to COPD exacerbation
Exclusion Criteria:
Patients admitted to hospital with COPD exacerbation
Other: CT pulmonary angio, blood tests
This study is status unknown, as verified in Mar 2010. You cannot join it, but the record below documents what was studied.
Get an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.
Hillel Yaffe Medical Center